Author(s)

Alyssa Damstrom¹, Saira Khan¹, Urma Jalil¹, Eno-Obong Effiong², Michael Corti^1,3, Hanady Zainah^1,4*

¹Lake Erie College of Osteopathic Medicine, Erie, USA.
²Department of Internal Medicine, St Johns’ Riverside Hospital, Yonkers, USA.
³Department of Hospital Medicine, St. John’s Riverside Hospital, Yonkers, USA.
⁴St. John’s Riverside Hospital, Yonkers, USA.

Leukocytoclastic vasculitis (LCV) is an immune-complex mediated inflammation of dermal capillaries and venules that can occur after infections, drugs, autoimmune disorders, neoplasms, or idiopathically. We present the case of a 59-year-old male who was treated with ceftriaxone for an abscess, S. aureus cellulitis, and osteomyelitis of his right second toe. Biopsy confirmed the diagnosis of LCV and symptoms resolved after ceftriaxone was discontinued and systemic corticosteroids were introduced.

Leukocytoclastic Vasculitis, Immune-Complex, Ceftriaxone, LCV

Damstrom, A. , Khan, S. , Jalil, U. , Effiong, E. , Corti, M. and Zainah, H. (2022) Leukocytoclastic Vasculitis Following Ceftriaxone Exposure. Open Journal of Nephrology, 12, 222-227. doi: 10.4236/ojneph.2022.122022.